MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations

Jan Trøst Jørgensen*, Edyta M Urbanska, Jens Mollerup

*Corresponding author for this work
Original languageEnglish
JournalTranslational lung cancer research
Volume13
Issue number4
Pages (from-to)940-946
Number of pages7
ISSN2218-6751
DOIs
Publication statusPublished - 29 Apr 2024

Keywords

  • capmatinib
  • companion diagnostics
  • MET exon 14-skipping mutations (METex14)
  • Non-small-cell lung cancer (NSCLC)
  • tepotinib

Cite this